Tech Company Financing Transactions
Mentara Therapeutics Funding Round
Mentara Therapeutics secured a funding round on 10/12/2026. Investors included SPRIM Global Investments and private investors.
Transaction Overview
Company Name
Announced On
10/12/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance its asset portfolio, scale up manufacturing operations, and launch a Phase 2 clinical study in the first half of 2027 evaluating its core asset for levodopa-induced dyskinesia (LID) in Parkinson's disease patients.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101, Level 1 117-119 Camberwell Road 1
Hawthorn East, Victoria, 3123
Australia
Hawthorn East, Victoria, 3123
Australia
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Mentara Therapeutics is a recently launched clinical-stage neuropsychiatry biotechnology company specializing in developing therapies for neurodegenerative and neurological disorders. Headquartered in Sydney, Australia, with historical ties to San Diego, California, the company officially debuted following its strategic spin-out/acquisition of key clinical assets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frank Stonebanks
Browse more venture capital transactions:
Prev: 10/12/2026: Sabi venture capital transaction
Next: 10/12/2026: Kapta Space venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs